From Bloomberg:
Sanofi-Aventis SA shares had their biggest drop in three years, wiping out more than $7 billion in market value, after a U.S. panel blocked the company’s new weight-loss pill because it was linked to suicides.
Says Derek Lowe:
Everyone will have heard the news about Wednesday’s FDA Advisory Commitee vote on Accomplia / Zimulti (rimonabant). [...]

[Read more →]